Comment on CMS-2026-1255-0001

Summary: The Sarcoma Foundation of America is submitting comments on behalf of patients with rare cancers, expressing concern that prior authorization requirements can delay critical diagnostic and biomarker testing. They urge CMS to adopt patient-centered standards, such as allowing retroactive authorizations and prohibiting timing-based denials, to ensure administrative processes do not hinder timely cancer care.